Industry Symposium 55

30 Mar 2026 5 p.m. 6 p.m.
315

Session Title: Comprehensive Management of Fabry Disease: Latest Evidence from Korea and Japan
Oganized by: Sanofi K.K.

Session Description:

This symposium brings together international nephrology experts to explore comprehensive monitoring strategies and therapeutic interventions for Fabry disease. Leading specialists will present cutting-edge evidence on multi-organ surveillance, early diagnostic approaches, and optimal treatment timing from an East Asian perspective. The session features Japanese research breakthroughs in Fabry disease management, fostering global knowledge exchange among WCN participants involved in Fabry disease care.

Learning Objectives:
Upon completion of this session, participants will be able to:
1.Apply early diagnostic approaches for Fabry disease using multi-organ monitoring strategies
2.Implement comprehensive monitoring protocols integrating renal and cardiac assessments
3.Optimize treatment intervention timing based on evidence-based criteria and biomarkers

Time Session
5 p.m.
6:20 p.m.
5:20 p.m.
5:40 p.m.
HidekiFujii Speaker fhideki@med.kobe-u.ac.jpJapan